Rein TherapeuticsRNTX
13F holders, Q1 2024 (March 31)23holders
2famous investors
$6.49avg. 13F price*
At the end of Q1 2024, 23 institutions reported holding Rein Therapeutics Inc. (RNTX) in their 13F filings. The largest holders were Alerce Investment Management, L.P. ($5.5M), Nantahala Capital Management, LLC ($1.7M) and Senvest Management, LLC ($1.3M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Rein Therapeutics Inc.
- Filed as
- AILERON THERAPEUTICS INC (Q1 2024)
- CUSIP
- 00887A204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $3.3M |
| Exits | 1 | $576 |
Ownership 23 holders
| Alerce Investment Management, L.P. | 5.79% | No change | 830,466 | $5.5M |
| Nantahala Capital Management, LLC | 0.17% | New | 255,000 | $1.7M |
| Senvest Management, LLC | 0.05% | New | 230,895 | $1.3M |
| Geode Capital Management, LLC | 0.00% | Add +21.8% | 69,759 | $453K |
| Sigma Planning Corp | 0.01% | Add +310.0% | 67,985 | $451K |
| Renaissance Technologies | 0.00% | Add +60.8% | 45,064 | $299K |
| Vanguard Group Inc. | 0.00% | No change | 40,314 | $267K |
| Gagnon Securities LLC | 0.06% | No change | 37,947 | $252K |
| Royal Bank of Canada | 0.00% | New | 36,000 | $239K |
| Blair William & Co. | 0.00% | No change | 28,297 | $188K |
| Texas Capital Bank Wealth Management Services Inc | 0.02% | Add +65.9% | 26,171 | $174K |
| Citadel Advisors | 0.00% | New | 13,810 | $90K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -9.3% | 2,020 | $13K |
| JFS Wealth Advisors, LLC | 0.00% | No change | 1,590 | $11K |
| US Bancorp \de | 0.00% | No change | 1,250 | $8K |
| Morgan Stanley | 0.00% | No change | 1,250 | $8K |
| FMR LLC | 0.00% | Add +366.0% | 233 | $2K |
| Bank of America Corp. | 0.00% | No change | 125 | $829 |
| ICA Group Wealth Management, LLC | 0.00% | No change | 100 | $663 |
| UBS Group AG | 0.00% | Reduce -95.7% | 93 | $617 |
| Game Plan Financial Advisors, LLC | 0.00% | No change | 50 | $332 |
| Wells Fargo & Company | 0.00% | Add +14.8% | 31 | $206 |
| Acadian Asset Management LLC | 0.00% | No change | 17 | $0 |
"% of holder's portfolio" is RNTX's weight in each manager's 13F, not the share of Rein Therapeutics Inc. the manager owns.